Reviewing the patent families in this subset reveals the following major patent entities. The figure below lists all the corporations with 100 or more patent families (tier 1) sorted by total inventions. Swiss multinational pharmaceutical company Novartis is revealed as the most active applicant at this scale of protection, followed closely followed by the Japanese multinational electronics corporation Panasonic. The next major entities in the list are covered by the German multinational engineering and electronics company Siemens, the American healthcare and products company Abbott Laboratories and finally Cochlear Limited, an Australian biotechnology company which designs, manufactures and supplies various implants
Table 15 – Tier 1 Patent Entities (Entity with 100 or more patent families)
Tier 1 Entity Ranking
|
Total Inventions
|
NOVARTIS
|
575
|
PANASONIC
|
545
|
SIEMENS
|
540
|
ABBOTT
|
518
|
COCHLEAR
|
434
|
VALEANT
|
419
|
NUANCE
|
345
|
ADVANCED BIONICS
|
341
|
EYE MICROSURGERY FEDOROV
|
289
|
JHONSON & JOHNSON
|
279
|
NEC
|
271
|
RION
|
256
|
IBM
|
249
|
SONY
|
238
|
NIDEK
|
234
|
MICROSOFT
|
231
|
NTT
|
212
|
CANON
|
205
|
TOSHIBA
|
195
|
AT&T
|
193
|
HITACHI
|
191
|
CARL ZEISS
|
182
|
SECOND SIGHT LLC
|
181
|
PHONAK
|
172
|
FUJITSU
|
159
|
WIDEX A/S
|
158
|
SEIKO EPSON
|
151
|
MED-EL ELECTROMEDIZINISCHE GERAETE GMBH
|
147
|
ALLERGAN
|
146
|
MITSUBISHI
|
146
|
MIKROKHIRURGIYA GLAZA SCI TECH COMPLEX
|
145
|
ESSILOR
|
137
|
MENICON
|
125
|
SAMSUNG
|
121
|
HOYA CORP
|
119
|
TOYOTA
|
114
|
PHILIPS
|
106
|
MOSC EYE DISEASE
|
100
|
The following table provides a timeline of patent activity for all large (tier 1) entities in the dataset.
Table 16 – Patent Activity for all large entities (tier1) in the Assistive Devices and Technologies for Visually and Hearing Impaired Persons Landscape
Tier 1 Entities
|
80
|
81
|
82
|
83
|
84
|
85
|
86
|
87
|
88
|
89
|
90
|
91
|
92
|
93
|
94
|
95
|
96
|
97
|
98
|
99
|
0
|
01
|
02
|
03
|
04
|
05
|
06
|
07
|
08
|
09
|
10
|
11
|
Total Inventions
|
NORVARTIS
|
-
|
3
|
2
|
-
|
5
|
6
|
1
|
3
|
9
|
5
|
12
|
9
|
10
|
7
|
8
|
19
|
15
|
19
|
22
|
22
|
24
|
13
|
35
|
20
|
39
|
21
|
69
|
49
|
22
|
39
|
26
|
26
|
575
|
PANASONIC
|
3
|
3
|
-
|
7
|
2
|
4
|
4
|
2
|
2
|
-
|
14
|
11
|
3
|
13
|
14
|
23
|
19
|
11
|
25
|
26
|
17
|
33
|
31
|
31
|
28
|
38
|
11
|
12
|
35
|
29
|
35
|
29
|
545
|
SIEMENS
|
3
|
6
|
7
|
7
|
10
|
8
|
23
|
20
|
9
|
7
|
3
|
2
|
2
|
1
|
5
|
9
|
12
|
11
|
16
|
18
|
18
|
11
|
23
|
19
|
14
|
24
|
46
|
86
|
78
|
21
|
9
|
2
|
540
|
ABBOTT
|
-
|
3
|
2
|
5
|
7
|
6
|
6
|
29
|
12
|
5
|
4
|
10
|
15
|
14
|
11
|
7
|
8
|
9
|
24
|
20
|
18
|
27
|
47
|
32
|
31
|
18
|
31
|
25
|
34
|
19
|
15
|
11
|
518
|
COCHLEAR
|
-
|
1
|
1
|
1
|
-
|
-
|
2
|
4
|
4
|
3
|
1
|
2
|
3
|
2
|
3
|
11
|
4
|
4
|
10
|
12
|
29
|
24
|
19
|
39
|
23
|
28
|
10
|
39
|
70
|
28
|
18
|
32
|
434
|
VALEANT
|
-
|
-
|
-
|
-
|
1
|
5
|
-
|
2
|
1
|
5
|
4
|
4
|
5
|
-
|
3
|
3
|
7
|
7
|
11
|
21
|
29
|
23
|
29
|
48
|
33
|
38
|
45
|
40
|
25
|
15
|
9
|
2
|
419
|
NUANCE
|
-
|
-
|
2
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
1
|
2
|
-
|
2
|
3
|
4
|
13
|
32
|
13
|
29
|
14
|
29
|
34
|
37
|
31
|
27
|
17
|
10
|
14
|
16
|
345
|
ADVANCED BIONICS
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
1
|
-
|
-
|
-
|
-
|
1
|
4
|
3
|
3
|
22
|
7
|
17
|
33
|
37
|
20
|
25
|
20
|
17
|
8
|
21
|
22
|
42
|
24
|
341
|
EYE MICROSURGERY FEDOROV
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
1
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
2
|
41
|
55
|
37
|
58
|
33
|
31
|
31
|
289
|
J&J
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
1
|
1
|
9
|
5
|
4
|
12
|
3
|
3
|
14
|
15
|
13
|
10
|
9
|
11
|
17
|
22
|
21
|
20
|
20
|
11
|
20
|
15
|
279
|
NEC
|
1
|
-
|
-
|
-
|
1
|
2
|
-
|
-
|
-
|
-
|
5
|
7
|
1
|
5
|
11
|
21
|
16
|
12
|
12
|
14
|
13
|
10
|
14
|
12
|
14
|
14
|
16
|
12
|
14
|
9
|
13
|
14
|
271
|
RION
|
-
|
16
|
2
|
8
|
7
|
12
|
-
|
6
|
3
|
2
|
5
|
8
|
3
|
10
|
16
|
27
|
6
|
8
|
12
|
10
|
3
|
3
|
5
|
6
|
9
|
9
|
12
|
11
|
13
|
6
|
3
|
6
|
256
|
IBM
|
-
|
-
|
-
|
-
|
1
|
-
|
-
|
1
|
1
|
1
|
-
|
7
|
7
|
1
|
2
|
5
|
2
|
7
|
10
|
12
|
13
|
34
|
9
|
16
|
15
|
18
|
17
|
12
|
19
|
18
|
2
|
7
|
249
|
SONY
|
2
|
1
|
1
|
1
|
-
|
-
|
1
|
5
|
-
|
-
|
3
|
5
|
6
|
9
|
12
|
14
|
10
|
10
|
12
|
15
|
13
|
4
|
6
|
16
|
9
|
14
|
3
|
9
|
12
|
9
|
13
|
12
|
238
|
NIDEK
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
2
|
2
|
4
|
2
|
6
|
7
|
8
|
5
|
7
|
8
|
8
|
16
|
25
|
15
|
16
|
14
|
11
|
18
|
14
|
14
|
16
|
13
|
234
|
MICROSOFT
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
1
|
5
|
4
|
3
|
5
|
10
|
8
|
10
|
13
|
18
|
25
|
25
|
19
|
17
|
15
|
15
|
12
|
18
|
231
|
NTT
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
2
|
1
|
-
|
3
|
8
|
12
|
8
|
6
|
6
|
7
|
6
|
7
|
9
|
16
|
18
|
19
|
9
|
17
|
15
|
10
|
11
|
12
|
212
|
CANON
|
1
|
1
|
1
|
1
|
2
|
3
|
4
|
3
|
3
|
2
|
1
|
3
|
1
|
12
|
8
|
1
|
2
|
8
|
5
|
6
|
11
|
12
|
14
|
21
|
19
|
20
|
12
|
9
|
12
|
5
|
2
|
|
205
|
TOSHIBA
|
1
|
-
|
-
|
-
|
-
|
-
|
1
|
3
|
1
|
-
|
1
|
1
|
3
|
5
|
6
|
10
|
11
|
6
|
3
|
10
|
4
|
12
|
9
|
7
|
9
|
8
|
12
|
15
|
18
|
11
|
9
|
11
|
195
|
AT&T
|
-
|
1
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
1
|
-
|
-
|
1
|
1
|
1
|
3
|
1
|
3
|
5
|
10
|
12
|
18
|
14
|
11
|
28
|
23
|
11
|
6
|
18
|
11
|
8
|
6
|
193
|
HITACHI
|
2
|
1
|
2
|
1
|
3
|
-
|
-
|
1
|
2
|
3
|
1
|
1
|
14
|
14
|
19
|
22
|
13
|
1
|
10
|
9
|
8
|
11
|
7
|
5
|
11
|
7
|
3
|
1
|
7
|
3
|
1
|
4
|
191
|
CARL ZEISS
|
-
|
-
|
-
|
2
|
1
|
1
|
-
|
-
|
2
|
-
|
-
|
2
|
1
|
2
|
2
|
3
|
3
|
4
|
3
|
11
|
2
|
6
|
4
|
15
|
7
|
12
|
23
|
17
|
15
|
14
|
10
|
15
|
182
|
SECOND SIGHT LLC
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
9
|
2
|
14
|
23
|
6
|
16
|
28
|
34
|
25
|
10
|
1
|
9
|
4
|
181
|
PHONAK
|
-
|
-
|
-
|
-
|
1
|
1
|
2
|
-
|
1
|
1
|
-
|
1
|
-
|
-
|
1
|
-
|
5
|
5
|
6
|
18
|
25
|
17
|
5
|
9
|
9
|
6
|
21
|
17
|
6
|
5
|
2
|
1
|
172
|
FUJITSU
|
-
|
-
|
-
|
-
|
2
|
1
|
-
|
-
|
-
|
-
|
4
|
2
|
3
|
11
|
7
|
10
|
9
|
8
|
3
|
4
|
3
|
6
|
8
|
6
|
5
|
5
|
11
|
16
|
10
|
11
|
5
|
7
|
159
|
WIDEX A/S
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
1
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
1
|
2
|
4
|
4
|
8
|
10
|
2
|
12
|
7
|
29
|
19
|
18
|
9
|
17
|
13
|
2
|
158
|
SEIKO EPSON
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
3
|
4
|
2
|
|
2
|
4
|
1
|
-
|
3
|
1
|
2
|
4
|
1
|
5
|
4
|
8
|
9
|
30
|
28
|
5
|
3
|
2
|
4
|
5
|
5
|
151
|
MED-EL ELECTROMEDIZINISCHE GERAETE GMBH
|
-
|
1
|
-
|
1
|
-
|
1
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
4
|
5
|
3
|
8
|
2
|
2
|
6
|
6
|
6
|
1
|
11
|
16
|
18
|
18
|
17
|
16
|
147
|
ALLERGAN
|
-
|
-
|
-
|
1
|
1
|
-
|
1
|
-
|
1
|
1
|
-
|
3
|
5
|
2
|
-
|
3
|
1
|
2
|
|
2
|
5
|
2
|
3
|
10
|
54
|
7
|
13
|
4
|
4
|
5
|
5
|
2
|
146
|
MITSUBISHI
|
-
|
-
|
-
|
-
|
1
|
-
|
-
|
-
|
3
|
-
|
-
|
1
|
-
|
2
|
9
|
3
|
4
|
5
|
2
|
6
|
7
|
11
|
12
|
5
|
5
|
18
|
11
|
6
|
12
|
8
|
4
|
5
|
146
|
MIKROKHIRURGIYA GLAZA SCI TECH COMPLEX
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
1
|
-
|
2
|
1
|
1
|
-
|
-
|
-
|
2
|
2
|
11
|
12
|
20
|
38
|
22
|
30
|
2
|
-
|
-
|
-
|
-
|
-
|
1
|
-
|
145
|
ESSILOR
|
-
|
-
|
1
|
-
|
-
|
-
|
-
|
2
|
4
|
5
|
2
|
4
|
-
|
-
|
-
|
3
|
1
|
4
|
4
|
5
|
7
|
5
|
3
|
13
|
12
|
9
|
15
|
9
|
4
|
9
|
6
|
9
|
137
|
MENICON
|
-
|
-
|
-
|
-
|
-
|
-
|
2
|
1
|
5
|
4
|
5
|
3
|
3
|
6
|
4
|
10
|
2
|
6
|
15
|
4
|
6
|
11
|
11
|
3
|
2
|
2
|
3
|
6
|
-
|
1
|
1
|
3
|
125
|
SAMSUNG
|
-
|
-
|
-
|
-
|
|
-
|
-
|
-
|
-
|
1
|
-
|
1
|
-
|
-
|
1
|
2
|
5
|
5
|
1
|
3
|
2
|
2
|
3
|
4
|
16
|
12
|
13
|
14
|
4
|
10
|
4
|
10
|
121
|
HOYA CORP
|
-
|
-
|
-
|
-
|
-
|
-
|
1
|
2
|
1
|
3
|
1
|
2
|
2
|
3
|
2
|
6
|
5
|
3
|
4
|
2
|
-
|
3
|
2
|
4
|
8
|
6
|
7
|
7
|
8
|
11
|
6
|
11
|
119
|
TOYOTA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
1
|
-
|
1
|
1
|
-
|
7
|
-
|
3
|
7
|
3
|
3
|
8
|
7
|
6
|
16
|
12
|
3
|
11
|
6
|
6
|
9
|
114
|
PHILIPS
|
1
|
1
|
1
|
-
|
1
|
-
|
-
|
1
|
3
|
1
|
-
|
5
|
3
|
1
|
3
|
-
|
-
|
4
|
4
|
3
|
5
|
9
|
8
|
10
|
4
|
10
|
6
|
3
|
8
|
4
|
2
|
-
|
106
|
MOSC EYE DISEASE
|
2
|
1
|
1
|
-
|
2
|
-
|
2
|
4
|
1
|
3
|
7
|
11
|
1
|
1
|
4
|
3
|
2
|
4
|
4
|
8
|
7
|
5
|
3
|
6
|
3
|
1
|
1
|
-
|
-
|
-
|
1
|
-
|
100
|
The following table provides a breakdown of the high level topics of interest to these listed corporations, as measured as a proportion of their complete vision and hearing impaired device portfolios.
Table 17 - Breakdown of Major Subject Matter of Entities as a number of all Patent Families per Portfolio in the assistive devices and technologies for Assistive Devices and Technologies for Visually and Hearing Impaired Persons Landscape
This table has been divided into two parts.
High Level Topics
|
NORVARTIS
|
PANASONIC
|
SIEMENS
|
ABBOTT
|
COCHLEAR
|
VALEANT
|
NUANCE
|
ADVANCED BIONICS
|
EYE MICROSURGERY FEDOROV
|
J&J
|
NEC
|
RION
|
IBM
|
SONY
|
NIDEK
|
MICROSOFT
|
NTT
|
CANON
|
TOSHIBA
|
AT&T
|
1.1 Vision Restoration
|
333
|
41
|
69
|
355
|
408
|
276
|
1
|
309
|
102
|
144
|
4
|
17
|
4
|
14
|
112
|
4
|
7
|
38
|
7
|
|
1.2 Hearing Restoration
|
1
|
80
|
157
|
|
106
|
|
1
|
71
|
|
1
|
4
|
126
|
1
|
23
|
|
|
3
|
1
|
1
|
|
2.1 Vision Assistance
|
24
|
107
|
29
|
58
|
1
|
10
|
15
|
3
|
5
|
8
|
96
|
2
|
83
|
31
|
80
|
25
|
39
|
58
|
42
|
9
|
2.2 Hearing Assistance
|
6
|
239
|
359
|
6
|
125
|
6
|
192
|
80
|
5
|
7
|
149
|
134
|
107
|
116
|
1
|
110
|
145
|
81
|
108
|
78
|
3.1 Vision Enhancement
|
58
|
45
|
18
|
99
|
3
|
19
|
30
|
2
|
44
|
49
|
60
|
|
88
|
25
|
94
|
27
|
21
|
45
|
22
|
13
|
3.2 Hearing Enhancement
|
1
|
135
|
114
|
|
254
|
1
|
19
|
238
|
|
4
|
31
|
51
|
15
|
39
|
3
|
22
|
27
|
9
|
17
|
15
|
4 Additional Related Technology
|
64
|
196
|
249
|
53
|
196
|
45
|
227
|
138
|
11
|
31
|
95
|
73
|
161
|
118
|
19
|
165
|
75
|
75
|
63
|
149
|
High Level Topics
|
HITACHI
|
CARL ZEISS
|
SECOND SIGHT LLC
|
PHONAK
|
FUJITSU
|
WIDEX A/S
|
SEIKO EPSON
|
MED-EL ELECTROMEDIZINISCHE GERAETE GMBH
|
ALLERGAN
|
MITSUBISHI
|
MIKROKHIRURGIYA GLAZA SCI TECH COMPLEX
|
ESSILOR
|
MENICON
|
SAMSUNG
|
HOYA CORP
|
TOYOTA
|
PHILIPS
|
MOSC EYE DISEASE
|
1.1 Vision Restoration
|
8
|
59
|
97
|
44
|
3
|
20
|
8
|
135
|
117
|
1
|
26
|
43
|
89
|
1
|
72
|
1
|
14
|
20
|
1.2 Hearing Restoration
|
10
|
|
|
49
|
2
|
59
|
2
|
25
|
|
|
|
|
|
3
|
|
|
10
|
|
2.1 Vision Assistance
|
71
|
16
|
8
|
4
|
37
|
|
53
|
1
|
5
|
34
|
1
|
6
|
5
|
23
|
2
|
10
|
20
|
5
|
2.2 Hearing Assistance
|
73
|
1
|
7
|
90
|
96
|
80
|
75
|
34
|
|
93
|
1
|
2
|
|
66
|
2
|
86
|
52
|
1
|
3.1 Vision Enhancement
|
29
|
28
|
162
|
2
|
20
|
|
30
|
5
|
7
|
17
|
30
|
19
|
9
|
15
|
8
|
9
|
20
|
18
|
3.2 Hearing Enhancement
|
25
|
|
31
|
55
|
16
|
62
|
8
|
102
|
|
5
|
|
|
|
10
|
|
8
|
11
|
1
|
4 Additional Related Technology
|
66
|
27
|
75
|
127
|
58
|
91
|
29
|
70
|
10
|
37
|
6
|
13
|
4
|
47
|
5
|
24
|
42
|
4
|
Table 18 - Breakdown of Major Subject Matter of Entities as a % of all Patent Families per Portfolio in the Assistive Devices and Technologies for Visually and Hearing Impaired Persons landscape
This table has been divided into two parts.
High Level Topics
|
NORVARTIS
|
PANASONIC
|
SIEMENS
|
ABBOTT
|
COCHLEAR
|
VALEANT
|
NUANCE
|
ADVANCED BIONICS
|
EYE MICROSURGERY FEDOROV
|
J&J
|
NEC
|
RION
|
IBM
|
SONY
|
NIDEK
|
MICROSOFT
|
NTT
|
CANON
|
TOSHIBA
|
1.1 Vision Restoration
|
58%
|
8%
|
13%
|
69%
|
94%
|
66%
|
0%
|
91%
|
35%
|
52%
|
1%
|
7%
|
2%
|
6%
|
48%
|
2%
|
3%
|
19%
|
4%
|
1.2 Hearing Restoration
|
0%
|
15%
|
29%
|
0%
|
24%
|
0%
|
0%
|
21%
|
0%
|
0%
|
1%
|
49%
|
0%
|
10%
|
0%
|
0%
|
1%
|
0%
|
1%
|
2.1 Vision Assistance
|
4%
|
20%
|
5%
|
11%
|
0%
|
2%
|
4%
|
1%
|
2%
|
3%
|
35%
|
1%
|
33%
|
13%
|
34%
|
11%
|
18%
|
28%
|
22%
|
2.2 Hearing Assistance
|
1%
|
44%
|
66%
|
1%
|
29%
|
1%
|
56%
|
23%
|
2%
|
3%
|
55%
|
52%
|
43%
|
49%
|
0%
|
48%
|
68%
|
40%
|
55%
|
3.1 Vision Enhancement
|
10%
|
8%
|
3%
|
19%
|
1%
|
5%
|
9%
|
1%
|
15%
|
18%
|
22%
|
0%
|
35%
|
11%
|
40%
|
12%
|
10%
|
22%
|
11%
|
3.2 Hearing Enhancement
|
0%
|
25%
|
21%
|
0%
|
59%
|
0%
|
6%
|
70%
|
0%
|
1%
|
11%
|
20%
|
6%
|
16%
|
1%
|
10%
|
13%
|
4%
|
9%
|
4 Additional Related Technology
|
11%
|
36%
|
46%
|
10%
|
45%
|
11%
|
66%
|
40%
|
4%
|
11%
|
35%
|
29%
|
65%
|
50%
|
8%
|
71%
|
35%
|
37%
|
32%
|
High Level Topics
|
AT&T
|
HITACHI
|
CARL ZEISS
|
SECOND SIGHT LLC
|
PHONAK
|
FUJITSU
|
WIDEX A/S
|
SEIKO EPSON
|
MED-EL ELECTROMEDIZINISCHE GERAETE GMBH
|
ALLERGAN
|
MITSUBISHI
|
MIKROKHIRURGIYA GLAZA SCI TECH COMPLEX
|
ESSILOR
|
MENICON
|
SAMSUNG
|
HOYA CORP
|
TOYOTA
|
PHILIPS
|
MOSC EYE DISEASE
|
1.1 Vision Restoration
|
0%
|
4%
|
32%
|
54%
|
26%
|
2%
|
13%
|
5%
|
92%
|
80%
|
1%
|
18%
|
31%
|
71%
|
1%
|
61%
|
1%
|
13%
|
20%
|
1.2 Hearing Restoration
|
0%
|
5%
|
0%
|
0%
|
28%
|
1%
|
37%
|
1%
|
17%
|
0%
|
0%
|
0%
|
0%
|
0%
|
2%
|
0%
|
0%
|
9%
|
0%
|
2.1 Vision Assistance
|
5%
|
37%
|
9%
|
4%
|
2%
|
23%
|
0%
|
35%
|
1%
|
3%
|
23%
|
1%
|
4%
|
4%
|
19%
|
2%
|
9%
|
19%
|
5%
|
2.2 Hearing Assistance
|
40%
|
38%
|
1%
|
4%
|
52%
|
60%
|
51%
|
50%
|
23%
|
0%
|
64%
|
1%
|
1%
|
0%
|
55%
|
2%
|
75%
|
49%
|
1%
|
3.1 Vision Enhancement
|
7%
|
15%
|
15%
|
90%
|
1%
|
13%
|
0%
|
20%
|
3%
|
5%
|
12%
|
21%
|
14%
|
7%
|
12%
|
7%
|
8%
|
19%
|
18%
|
3.2 Hearing Enhancement
|
8%
|
13%
|
0%
|
17%
|
32%
|
10%
|
39%
|
5%
|
69%
|
0%
|
3%
|
0%
|
0%
|
0%
|
8%
|
0%
|
7%
|
10%
|
1%
|
4 Additional Related Technology
|
77%
|
35%
|
15%
|
41%
|
74%
|
36%
|
58%
|
19%
|
48%
|
7%
|
25%
|
4%
|
9%
|
3%
|
39%
|
4%
|
21%
|
40%
|
4%
|
In terms of vision, from this analysis we can see that Cochlear (94%), Austrian biotechnology company Med-El Electromedizinische Geraete GmbH (92%) and the American technology device company Advanced Bionics (91%) and have a strong specialization and commercial interest in Vision Restoration, with a high proportion of their portfolio’s directed to this technology. American medical product company Second Sight LLC has as high commercial interest in Vision Enhancement with 90% of its portfolio directed to this technology.
In relation to hearing technology, there are more entities that appear to share this landscape with a much larger amount of tier 1 entities having relatively large amounts of their portfolio’s directed toward hearing related technology. Some stand out companies include, the Japanese medical devices company Rion in the hearing restoration technology field, Japanese telecommunications company NTT (Nippon Telegraph and Telephone) in relation to hearing assistance and Advanced Bionics (70%) in relation to hearing enhancement.
Interestingly, it appears that a great deal of tier 1 (similar trends are observed across the dataset as a whole) entities have a significant number of their patent innovation directed to both vision and hearing device applications as shown by their high patent numbers indicated in both the vision and hearing aspects of this technology.
Share with your friends: | 
